College Station, Texas, October 24 2022 — FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced today a strategic collaboration with RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services. Through this collaboration, FUJIFILM Diosynth Biotechnologies will incorporate RoosterBio’s industry-leading process development technology for both MSC and extracellular vesicle (EV) / exosome programs into its manufacturing capabilities and offerings. [Read more…]
Approved Exosome Diagnostics: ExoDx Prostate IntelliScore & Guardant360 CDx
While solid biopsies have several limitations, including but not limited to their invasive nature, liquid biopsies can offer a promising alternative. Today, a growing number of companies are developing exosome diagnostics for the non-invasive detection and prognosis of cancer and other serious medical conditions. This approach is effective because exosomes are present in almost all body fluids and critical valuable information about the cells from which they were released. [Read more…]
3 PhD students from King’s College London win the $100,000 Stem Cell SpaceShot grant
Bordeaux, France, Cambridge (MA), USA / October 20th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced that an international team composed of 3 PhD students from King’s College London has been awarded the Stem Cell SpaceShot grant. With this $100,000 research funding, Matthew Wai Heng CHUNG, Cher Shen KIAR & Sofia SYNTAKA will explore the reprogramming of stem cell-derived macrophages, with the aim of repairing neuronal damage, such as spinal cord injury. [Read more…]
Greenstone Bio Secures $1.3M from CIRM for iPSC-derived Cardiovascular Cell Technologies
CIRM awards $1.3M to Greenstone Bio for stem cell research involving iPSC-derived cardiovascular cells accelerated by artificial intelligence and machine learning.
Palo Alto, CA, Oct 04, 2022 – Greenstone Biosciences, Inc. (“Greenstone Bio”), a commercial-stage computational biology company, announces that the Company has received a DISC0 grant funding from the California Institute of Regenerative Medicine (CIRM). [Read more…]
Americord® Releases Exosomes Banking with CryoMaxx™ Processing
Americord Registry announces the addition of exosome banking to their suite services, becoming the first company in the United States to do so.
NEW YORK, NEW YORK, US, October 11, 2022 – Americord Registry®, a leader in the cord blood industry, announced the addition of exosome banking to their suite of family-focused services, becoming the first private biobanking company in the United States to do so. Exosomes are tiny, extracellular vesicles that initiate cell-to-cell communication by shuttling cellular components to other cells. Pre-clinical research has shown that exosomes may regulate immune responses, wound healing, and cell growth and development. [Read more…]
- « Previous Page
- 1
- …
- 140
- 141
- 142
- 143
- 144
- …
- 338
- Next Page »